Redhill生物制药 RDHL 深 沪
已收盘 09-19 16:00:00 美东时间
1.69
-0.010
-0.59%
华盛通- 最 高1.72
- 今 开1.72
- 成交量 2.78万股
- 最 低 1.63
- 昨 收 1.7001
- 总市值 387.28万
- 52周最高 9.0499
- 市盈率 静 0.02
- 换手率 1.21%
- 52周最低 1.06
- 委 比 -42.05%
- 总股本 229.16万
- 历史最高 22220.00
- 量 比 0.60
- 振 幅 5.29%
- 历史最低 1.06
- 每 手 1
- 风险率 9.47%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多RedHill Biopharma Reports Strong Progress in 2025
RedHill Biopharma Ltd ( ($RDHL) ) has released its Q2 earnings. Here is a break...
09-12 11:51
Blue Ops Taps Hodgdon Shipbuilding for USV Prototypes; Leases Georgia Factory to Scale U.S. Production
Red Cat Holdings' Blue Ops division expands manufacturing capabilities with new facilities in Maine and Georgia, supporting USV production and innovation. Prototypes are being built in Maine, with Georgia serving as a major production hub, creating jobs and strengthening the defense industrial base. The new facilities, along with a Florida headquarters, aim to enhance U.S. maritime defense capabilities, supported by partnerships and strategic inv...
09-09 13:42
Redhill Biopharma H1 Sales $4.079M Up From $2.572M YoY
Redhill Biopharma (NASDAQ:RDHL) reported $4.079 million in sales this quarter. This is a 58.59 percent increase over sales of $2.572 million the same period last year.
09-05 19:10
RedHill GAAP EPS of $0.00, revenue of $4.08M
RedHill press release (NASDAQ:RDHL): 1H GAAP EPS of $0.00. Revenue of $4.08M (+58.8% Y/Y). More on RedHill Financial information for RedHill
09-05 19:03
RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights
Extensive strategic, financial and operational overhaul has reshaped and refocused our business; Strong progress on multiple fronts Commercial and R&D Highlights: Recruitment initiated in th...
09-05 19:00
RedHill Biopharma Secures $1.1 Million from Talicia’s First International Sales
RedHill Biopharma ( ($RDHL) ) has issued an update. On August 18, 2025, RedHill...
08-18 21:27
RedHill received Talicia licensing payments totaling $1.1 million
RedHill Biopharma (NASDAQ:RDHL) on Monday announced that it has received its first Talicia ex-U.S. sales milestone, royalties and other payments totaling approximately $1.1 million. Talicia is the fir...
08-18 21:20
RedHill Received Talicia® Licensing Payments Totaling $1.1 Million
RedHill has received its first Talicia sales milestone payment as well as royalties and other payments, totaling $1.1 million, following the first ex-U.S. commercial launch of Talicia in 202...
08-18 21:00
RedHill Biopharma Granted Nasdaq Compliance Extension
RedHill Biopharma ( ($RDHL) ) just unveiled an announcement. On August 8, 2025,...
08-14 19:28
RedHill Biopharma Gains FDA Support for Innovative Crohn’s Disease Therapy
An update from RedHill Biopharma ( ($RDHL) ) is now available. On July 21, 2025...
07-21 21:27
